Page 31 - Annual Report 2021

instituted its Improvement Satisfaction capture the high-growth high-revenue sectors, there is healthy potential for
index and the UMSC Level of Authority market segment of the healthcare growth. Malaysia projects increasing
(LOA), completed the issuance of sector. Meanwhile, Pharmauji will demand for healthcare services due to
SOPs at UMSC level, and introduced focus on the development and its ageing population, rising affluence
High Performance Team Values and commercialisation of pharmaceutical and higher life expectancy. The same
Efficient Management of Incident products, biosimilar products and
Reporting under Clinical Services (< medical devices. factors are expected to drive the
24hrs). growth of Malaysia’s pharmaceutical
Although healthcare and market to a projected value of RM127b
Planning of the new hospital building pharmaceuticals are highly competitive by 2027.
to house cutting-edge facilities and
services to support UMSC’s envisioned
position as Malaysia’s Premier
Quaternary Hospital were also put into
motion in 2021.

Prospects
For FY2022 and beyond, the Group
intends to position UMSC as the
nation’s premier quaternary hospital to

In the immediate and short-term,
UMSC is targeting to further improve
its operational excellence, its customer
and stakeholder satisfaction efforts,
and to embark on a major expansion
drive to achieve the envisioned status of
Premier Quaternary Hospital.

To raise operational excellence, UMSC
intends to:

• Adopt technological advances
including the new Hospital
Information System to enhance
automation of processes and drive
efficiency.
• Enhance its talent retention
programme to address people
issues, especially the nursing
shortage which affects quality of
nursing and overall services.
• Continue improving infrastructure
through renovation and refurbishment

Annual Report 2021 31